Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PORTHOS: Ceftriaxone PK in Septic ICU Patients
NCT00449800Phase 4Unknown
- Sponsor
- Association pour la Promotion à Tours de la Réanimation Médicale
- Start
- Jul 2006
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, open-label trial of ceftriaxone in sepsis and septic shock, sponsored by Association pour la Promotion à Tours de la Réanimation Médicale. Primary endpoints: Serum drug concentration at Day 5, Pharmacokinetics parameters at Day 5 and 1 more. Status: unknown.
02
Drugs
ceftriaxone
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT00449800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449800.